JPS61149863A - Measuring method of biotin and reagent for measurement to be used therein - Google Patents
Measuring method of biotin and reagent for measurement to be used thereinInfo
- Publication number
- JPS61149863A JPS61149863A JP27252884A JP27252884A JPS61149863A JP S61149863 A JPS61149863 A JP S61149863A JP 27252884 A JP27252884 A JP 27252884A JP 27252884 A JP27252884 A JP 27252884A JP S61149863 A JPS61149863 A JP S61149863A
- Authority
- JP
- Japan
- Prior art keywords
- biotin
- liquid
- labeling
- examined
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はビオチンの測定法およびこれに用いる測定用試
薬に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for measuring biotin and a measuring reagent used therefor.
ビオチンは生体内の糖質・脂質代謝系等において炭酸固
定および炭酸転移反応に関与しているビタミンであり、
その欠乏症としては痛痒性皮膚炎、舌炎、抑うつ状態等
の報告がある。人におけるビオチン欠乏症は生卵を大量
に摂取したとき以外はほとんど発現しないとされている
が、長期の高力aリー輸液施行患者ではビオチン欠乏症
の報告もあシ、これらの患者については、ビオチン量を
測定する必要がある。ビオチン量を測定する方法として
は、血中又は尿中のビオチンを測定することが一般的で
あり、現在、微生物学的定量法が用いられている。Biotin is a vitamin that is involved in carbonic acid fixation and carbonic acid transfer reactions in the carbohydrate and lipid metabolic systems in living organisms.
Deficiency symptoms such as itchy dermatitis, glossitis, and depression have been reported. Biotin deficiency in humans is said to rarely occur except when large amounts of raw eggs are ingested, but biotin deficiency has also been reported in patients who have undergone long-term high-strength aliquot infusions, and these patients have a low biotin level. need to be measured. A common method for measuring the amount of biotin is to measure biotin in blood or urine, and microbiological quantitative methods are currently used.
通常ビオチンは血中では大部分が蛋白質と強固に結合し
ており、血中濃度を測定するためにはまず蛋白質を加水
分解してビオチンを遊離しなければならない。このため
の加水分解の方法としては硫酸による方法、パパインに
よる方法などが用いられている。Normally, most biotin in blood is tightly bound to proteins, and in order to measure the blood concentration, biotin must first be liberated by hydrolyzing proteins. As a hydrolysis method for this purpose, a method using sulfuric acid, a method using papain, etc. are used.
しかしながら、微生物学的定量法による正常人の血中ビ
オチンの量は、その加水分解法や定量に用いる菌種など
によりかなり異なっていることが知られていた。これは
、菌種によっては結合型ビオチンやビオチン類似物質を
も利用できること、オレイン酸やリノール酸など不飽和
脂肪酸がビオチンの代用になること等の理由によるため
である。However, it has been known that the amount of biotin in the blood of normal people determined by microbiological quantitative methods varies considerably depending on the hydrolysis method and the bacterial species used for the quantitative determination. This is because, depending on the bacterial species, bound biotin or biotin-like substances can also be used, and unsaturated fatty acids such as oleic acid and linoleic acid can be substituted for biotin.
また微生物学的定量法自体も操作が繁雑であること、測
定結果がでるまでに長時間(24〜72時間)かかるこ
と、検体量が多量(血液1〜21E/)に必要なこと吟
の欠点があった。したがって、微生物学的定量法にかわ
る、容易にかつ正確にビオチン量を測定する方法の開発
が要望されていた。In addition, the microbiological quantitative method itself is complicated to operate, takes a long time (24 to 72 hours) to produce measurement results, and requires a large amount of sample (1 to 21 E/blood). was there. Therefore, there has been a demand for the development of a method for easily and accurately measuring the amount of biotin in place of microbiological quantitative methods.
斯かる実情において、本発明者は、上記欠点を克服せん
と鋭意研究を行なった結果、ビオチン化蛋白質へのアビ
ジンの結合反応が遊離のビオチンによって阻害されるこ
と、そしてこの特異的な結合反応を利用すれば容易かつ
正確に被検液中のビオチン量を測定することができるこ
とを見出し、本発明を完成した@
すなわち、本発明は、固定化−ビオチン化蛋白質にビオ
チン含有の被検液および標識アビジンを加え、当該ビオ
チン化蛋白質に結合した標識体活性を測定し、これを標
準液のそれと比較することを特徴とするビオチンの測定
法を提供するものである。Under these circumstances, the present inventor conducted intensive research to overcome the above-mentioned drawbacks, and found that the binding reaction of avidin to biotinylated proteins is inhibited by free biotin, and that this specific binding reaction is inhibited by free biotin. The present invention was completed based on the discovery that the amount of biotin in a test solution can be easily and accurately measured by using the method. The present invention provides a method for measuring biotin, which is characterized by adding avidin, measuring the activity of a label bound to the biotinylated protein, and comparing this with that of a standard solution.
更に、本発明は、この測定に使用する標識アビジンおよ
び固定化−ビオチン化蛋白質を含有するビオチン測定用
試薬を提供するものである。Furthermore, the present invention provides a biotin measurement reagent containing labeled avidin and immobilized biotinylated protein used in this measurement.
本発明方法で用いる標識アビジンとしては、例えばニワ
トリ卵白中に含まれる塩基性のアルブミン様結晶蛋白質
であるアビジンを標識したものが挙げられる。標識は、
例えばパーオキシダーゼ、ベータ・ガラクトシダーゼ、
アルカリホスファターゼなどの酵素による標識が、測定
の容易さから好ましい。Examples of the labeled avidin used in the method of the present invention include labeled avidin, which is a basic albumin-like crystal protein contained in chicken egg white. The sign is
For example, peroxidase, beta-galactosidase,
Labeling with an enzyme such as alkaline phosphatase is preferred for ease of measurement.
また固定化−ビオチン化蛋白質としては、蛋白質をビオ
チン化し更にこれを常法により固定化したものが使用さ
れる。ビオチン化される蛋白質としては、アルブミン、
グロブリン、リゾチーム及び側鎖にアミノ基を有するポ
リアミノ酸等の一般的な蛋白質が挙げられ、また固定化
にはプラスティック性の容器、例えばポリスチレン、ポ
リビニールトルエン、ポリブタジェン等の容器が使用さ
れる。Further, as the immobilized-biotinylated protein, a protein obtained by biotinylating and further immobilizing this by a conventional method is used. Proteins that are biotinylated include albumin,
General proteins such as globulin, lysozyme, and polyamino acids having amino groups in their side chains can be mentioned, and plastic containers such as polystyrene, polyvinyl toluene, polybutadiene, etc. are used for immobilization.
蛋白質のビオチン化は、N−ヒドロキシスクシンイミド
ビオチン等のビオチン誘導体と蛋白質を溶媒中で反応せ
しめることによって行なわれる。Biotinylation of proteins is carried out by reacting the protein with a biotin derivative such as N-hydroxysuccinimide biotin in a solvent.
反応に当ってのビオチン誘導体と蛋白質の重量比は、例
えば、ポリリジンを用いた場合には1:1〜1:20の
範囲、特に1:5付近が好ましい。The weight ratio of the biotin derivative to the protein in the reaction is preferably in the range of 1:1 to 1:20, particularly around 1:5 when polylysine is used.
ビオチン化蛋白質の固定化は公知の方法によシ行なうこ
とができるが、例えばビオチン化ポリリジンを用いた場
合は、0.05〜1.0慢ポリリジン濃度で、40〜5
0℃、30〜60分の条件下で行なうのが好まし・い。Immobilization of biotinylated proteins can be carried out by known methods; for example, when biotinylated polylysine is used, it is possible to
It is preferable to carry out the reaction at 0°C for 30 to 60 minutes.
本発明方法を実施するには、上記方法よシ得た固定化−
ビオチン化蛋白質に、標識アビジンとビオチンを含有す
る被検液を加え、固定化−ビオチン化蛋白質に結合した
標識体活性をビオチン標準液の場合と比較すれば良い。To carry out the method of the present invention, the immobilization obtained by the above method -
A test solution containing labeled avidin and biotin may be added to the biotinylated protein, and the activity of the labeled substance bound to the immobilized biotinylated protein may be compared with that of a biotin standard solution.
本発明方法において添加する標識アビジンは10〜10
00 nt/114 、特に20〜100 ny/at
であることが好ましい。The amount of labeled avidin added in the method of the present invention is 10 to 10
00 nt/114, especially 20-100 ny/at
It is preferable that
本発明の好ましい実施態様は次のとおりである。Preferred embodiments of the present invention are as follows.
■ ビオチン化蛋白質を固定化した96穴U底プレート
の各穴に、pH5〜8の0.01〜0.2Mリン酸緩衝
生理食塩水(以下、PBSと略す)で調製した被検液ま
たはビオチン標準液を25〜100μ!入れる。■ A test solution prepared with 0.01-0.2M phosphate buffered saline (hereinafter abbreviated as PBS) with pH 5-8 or biotin was added to each well of a 96-well U-bottom plate on which biotinylated protein was immobilized. 25-100 μ of standard solution! put in.
■ これに、20 = 100 ny/dの標R7ビジ
ンPBS溶液25〜I Q Oplt−加え、良く混和
する。(2) Add 20 = 100 ny/d standard R7 Vidine PBS solution 25~I Q Oplt- to this and mix well.
■ 0.5〜4時間放置して反応を完結させた後上清を
すてる。(2) Allow to stand for 0.5 to 4 hours to complete the reaction, then discard the supernatant.
■ 標識体に対する基質溶液を加えて発色させ、それぞ
れの吸光度を測定して標識体活性を測定する。(2) Add a substrate solution for the label to develop color, and measure the absorbance of each to measure the activity of the label.
■ 被検液と標準液とにおける標識体活性を比較して被
検液中のビオチン量を算出する。■ Calculate the amount of biotin in the test solution by comparing the labeled activity in the test solution and the standard solution.
尚本発明方法においては、非特異的な反応を防ぐタメ、
PR8K0.05〜1.Otsの血清アルフミンや動物
血清等の蛋白質および0.01〜0.5sのポリオキシ
エチレンソルビタンモノラウレート(Tween −2
0)等を加えるのが望ましい。In addition, in the method of the present invention, in order to prevent non-specific reactions,
PR8K0.05~1. Proteins such as Ots serum albumin and animal serum, and 0.01-0.5s polyoxyethylene sorbitan monolaurate (Tween-2
0) etc. is desirable.
本発明方法によれば、必要とされる被検液量は、微生物
定量の場合の約115oであり、また測定に用する時間
も微生物定量の24〜72時間に対し、本性は5時間と
短縮された。さらに測定操作が非常に簡単であるため一
度に大量の検体の測定が可能となった(1枚の96穴U
底プレートで約20検体が測定可能であ91日−人当り
200以上もの検体を処理できる)。したがって本発明
は多くの検体を同時に測定し九い場合、例えば輸液施行
患者の栄養状態をモニターする際の血中、尿中ビオチン
を測定する場合等に特に有利である。According to the method of the present invention, the amount of test liquid required is approximately 115° for microbial quantification, and the time required for measurement is shortened to 5 hours, compared to 24 to 72 hours for microbial quantification. It was done. Furthermore, the measurement operation is extremely simple, making it possible to measure a large number of samples at once (96 holes on one sheet).
Approximately 20 samples can be measured on the bottom plate and more than 200 samples per person can be processed for 91 days). Therefore, the present invention is particularly advantageous when many specimens need to be measured simultaneously, such as when measuring biotin in blood or urine when monitoring the nutritional status of a patient undergoing infusion.
次に実施例を挙げて本発明の詳細な説明する。 Next, the present invention will be explained in detail with reference to Examples.
実施例1゜
固定化−ビオチン化ポリリジンの作製:1)N−ヒドロ
キンスクシンイミドビオチン(NHSビオチン;フナコ
シ薬品)1キを50μeのジメチルホルムアミドに溶解
し、これに1〜/mlのポリリジン0.1M炭酸水素ナ
トリウム溶液5M(ポリーL−リジン;シグマP−26
36)を加えて室温で4時間反応し、4℃で保存するか
、凍結乾燥して保存し、用時所定の濃度に希釈して使用
する。Example 1 Preparation of immobilization-biotinylated polylysine: 1) Dissolve 1 kg of N-hydroquine succinimide biotin (NHS biotin; Funakoshi Pharmaceutical) in 50μe of dimethylformamide, and add 0.1M of polylysine at 1~/ml to this. Sodium bicarbonate solution 5M (poly L-lysine; Sigma P-26
36), react at room temperature for 4 hours, store at 4°C, or freeze-dry and store, and dilute to a predetermined concentration before use.
it) 次に1)で得たビオチン化ポリリジン0,0
1チ溶液(0,01MPBS、 p)17.2) 10
0μl’c96穴U底プレートに入れ、60分間、45
℃に保つ。今後、0.01MPB S (pH7,2)
で洗浄し、0.5%カゼイン0.0℃MPH8(出7.
2)溶液250μg′t−加えて25℃、60分間処理
を行なう。終了後、まず0.01MPBS(pH7,2
)、次いで0.05 % Tween −20含有0.
1MPR8(pH7,2)で充分に洗浄する。it) Next, biotinylated polylysine 0,0 obtained in 1)
1-chi solution (0.01MPBS, p) 17.2) 10
Pour 0 μl into a 96-well U-bottom plate and incubate for 60 minutes at 45
Keep at ℃. From now on, 0.01MPBS (pH7,2)
Wash with 0.5% casein at 0.0°C MPH8 (7.
2) Add 250 μg't of the solution and treat at 25° C. for 60 minutes. After finishing, first add 0.01MPBS (pH 7,2
), followed by 0.05% Tween-20.
Wash thoroughly with 1MPR8 (pH 7,2).
実施例2゜
ラット血中ビオチン濃度の測定:
(1) 凍結融解により溶血したラット血液50μg
にパパイン液(シグマP−3125)10μlおよび4
.4mMりx7酸−11,2mM Nat HPO4緩
衝液190μet−混和し、トルエン1滴を加えて37
℃で一夜反応後オートクレープ(121’c i o分
)処理し、8000 rpmで5分間遠心分離後、その
上清1 pH6,0に修正する。次にジエチルエーテル
0.25 mを加え、良く振盪後、エーテル層を除き、
水 に1ゴのエチルアルコールを加えて混和後、800
0rprn5分間の遠心上清をとる。これを吸引乾固し
、0.1MPBS(pH7,2)200μ6Km屏して
被検液とした。Example 2 Measurement of biotin concentration in rat blood: (1) 50 μg of rat blood hemolyzed by freezing and thawing
10 μl of papain solution (Sigma P-3125) and 4
.. Mix 4mM 7-acid-190μ of 2mM Nat HPO4 buffer, add 1 drop of toluene and
After overnight reaction at °C, the mixture was autoclaved (121'Cio min), centrifuged at 8000 rpm for 5 minutes, and the pH of the supernatant 1 was adjusted to 6.0. Next, add 0.25 m of diethyl ether, shake well, remove the ether layer,
Add 1 cup of ethyl alcohol to water and mix, then add 800
Collect the supernatant after centrifugation at 0 rpm for 5 minutes. This was suctioned to dryness and filtered with 200μ6km of 0.1MPBS (pH 7,2) to obtain a test solution.
ビオチン化ポリリジンを固定化した96穴U底プレート
の各穴に0.4チ牛血清アルプミ7CBSA )及び0
.14Tween−20含有0.1MPBS(pH7,
2)で調製した8 0 ny/nl ノアビジン・パー
オキシダーゼ(フナコシ薬品)溶液50μlt−加え、
さらに被検液、又はビオチン標準液(0,0,125,
0,25,0,5又は1.0 ny/ml ) 507
16を加えてよく混和する。In each well of a 96-well U-bottom plate immobilized with biotinylated polylysine, 0.4 μl of bovine serum Alpumi 7CBSA) and 0
.. 14Tween-20-containing 0.1MPBS (pH 7,
Add 50 μlt of the 80 ny/nl noavidin peroxidase (Funakoshi Pharmaceutical) solution prepared in 2),
Furthermore, test solution or biotin standard solution (0, 0, 125,
0,25,0,5 or 1.0 ny/ml) 507
Add 16 and mix well.
25℃で120分間反応後、上清を除き、0.05%
Tvreen −20含有0.1MPBS(p)f7.
2)で充分洗浄後0.01 v/v%過酸化水素を含む
3q/ldオルト・フェニレンジアミン0.01MPB
S(pH6,0)尋禁250pe k各穴lc入し37
℃で30分間反応する。終了後、上清200μeにIN
−硫酸2yt−加えて、その492nmにおける吸光度
を測定する。ビオチン標準液より得た検量線から、血中
ビオチン濃度を求めたところ2.14±0.08 ny
74tlであった。同一血液2m1f同様にパパインで
加水分解して、微生物学的定量法により血中ビオチン濃
度を求めたところ2.46 nf/R1であった。After reacting at 25°C for 120 minutes, remove the supernatant and add 0.05%
0.1 MPBS (p) f7. containing Tvreen-20.
After thorough washing with 2), add 0.01 MPB of 3q/ld ortho-phenylenediamine containing 0.01 v/v% hydrogen peroxide.
S (pH 6,0) interrogation 250pe k each hole with lc 37
React for 30 minutes at °C. After finishing, add 200 μe of supernatant to
-2yt of sulfuric acid- is added and its absorbance at 492 nm is measured. The blood biotin concentration was determined from the calibration curve obtained from the biotin standard solution and was 2.14±0.08 ny.
It was 74 tl. 2ml of the same blood was similarly hydrolyzed with papain, and the blood biotin concentration was determined by microbiological quantitative method, and it was found to be 2.46 nf/R1.
(2)う1)血液50μJK0.05N硫酸150μ/
を加えてオートクレーブ(121°C)で60分間加水
分解し、8000rpm5分間の遠心上清をとる。これ
に200μgのジエチルエーテルを加え、良く振盪後、
エーテル層を除き、水層に1.0−のエチルアルコール
を加えて混和後8000 rpm 5分間の遠心上清を
とる。こしt−吸引乾固シ、0.1 M P B S
CpH7,2) 200μgに溶解して被検液とした。(2) U1) Blood 50μJK0.05N sulfuric acid 150μ/
was added and hydrolyzed in an autoclave (121°C) for 60 minutes, and the supernatant was centrifuged at 8000 rpm for 5 minutes. Add 200μg of diethyl ether to this, shake well,
Remove the ether layer, add 1.0-ethyl alcohol to the aqueous layer, mix, and centrifuge at 8000 rpm for 5 minutes to collect the supernatant. Strain and evaporate to dryness, 0.1 M P B S
CpH7,2) was dissolved in 200 μg to prepare a test solution.
これ全実施例2、(IIと同様の定量操作全行ない血中
ビオチン濃度を求めたところ1.91±0.07 ny
/mlであった。同一血液2rILlを同様に硫酸で加
水分解して微生物学的定量法により血中ビオチン濃度を
求めたところ1.64 ny/atであった。本法によ
り少量の血液でパパイン処理法、硫酸処理法ともに従来
法とほぼ同じ測定結果が得られ丸。The blood biotin concentration was determined by carrying out all the same quantitative operations as in Example 2 (II) and found to be 1.91±0.07 ny
/ml. The same blood 2rILl was similarly hydrolyzed with sulfuric acid and the blood biotin concentration was determined by a microbiological quantitative method and was found to be 1.64 ny/at. With this method, almost the same measurement results as conventional methods can be obtained with both papain treatment and sulfuric acid treatment using a small amount of blood.
実施例3゜
ウサギ血中ビオチン濃度の測定:
(1)凍結融解によシ溶血したウサギ血液50plにパ
パイン液(シグマP−3125)10μlを加え、実施
例2.(11と同様に処理して被検液を調製し、さらに
同様の操作により血中ビオチン濃度を求めたところ1.
58±0.16np/−であつ九。同一血液2プを同様
にパパインで加水分解して、微生物学的定量法により血
中ビオチン濃度を求めたところ1.46 ny/mlで
あった。Example 3 Measurement of biotin concentration in rabbit blood: (1) 10 μl of papain solution (Sigma P-3125) was added to 50 pl of rabbit blood hemolyzed by freeze-thawing. (A test solution was prepared in the same manner as in 11, and the blood biotin concentration was determined in the same manner as in 1.
58±0.16np/-. Two samples of the same blood were similarly hydrolyzed with papain, and the blood biotin concentration was determined by a microbiological quantitative method and was found to be 1.46 ny/ml.
+21つfギ血液50 filVc 0.05N(ff
l酸150/j/全加えてオートクレーブ(121℃)
で60分間加水分解し、以下実施例2. (21と同様
に処理して被検液を調製し、さらに実施例2.+I+と
同様の操作によシ血中ビオチン濃度を求めたところ、1
.18±0.17 ny7mlであった。同一血液2
ml? t−同様に硫酸で加水分解して微生物学的定量
法によシ血中ビオチン濃度を求めたところ、0.95n
t/ゴであった。本法により少量の血液でパパイン処理
法、硫酸処理法ともに従来法とほぼ同じ測定結果が得ら
れた。+21 f blood 50 filVc 0.05N (ff
Add l acid 150/j/all and autoclave (121℃)
The following example 2. (A test solution was prepared in the same manner as in Example 2.21, and the blood biotin concentration was determined in the same manner as in Example 2.+I+.
.. It was 18±0.17 ny7ml. Same blood 2
ml? t- When the blood biotin concentration was similarly determined by the microbiological quantitative method after hydrolysis with sulfuric acid, it was found to be 0.95n.
It was t/go. With this method, almost the same measurement results as the conventional method were obtained for both papain treatment and sulfuric acid treatment using a small amount of blood.
実施例4゜
ヒト尿中ビオチン濃度の測定:
ヒト尿を0.1MPBS (pH7,2)で30倍希釈
して被検液とした。実施例2.(11と全く同様p操作
によシ尿中ビオチン濃度を求めたところ、16.7±2
.5 np /mlであった。同−尿を微生物学的定量
法によシビオチン濃度を測定したところ、15.8 n
y/ldであった。本法によシ短時間で従来法とほぼ同
様の測定結果が得られた。Example 4 Measurement of biotin concentration in human urine: Human urine was diluted 30 times with 0.1 MPBS (pH 7,2) to prepare a test solution. Example 2. (The urinary biotin concentration was determined by the p operation exactly as in 11, and was found to be 16.7 ± 2.
.. It was 5 np/ml. When the sybiotin concentration of the same urine was measured using a microbiological quantitative method, it was found to be 15.8 n
It was y/ld. Using this method, almost the same measurement results as the conventional method were obtained in a short time.
実施例5゜
1、ビオチン標準品
a、 ビオチン 1.0ny塩
化ナトリウム 8.8キリン醗−ナト
リウム(2水塩) 4.411Fリン酸二ナトリウム
(12水塩)25.811fb、 ビオチン
0.5nt塩化ナトリウム
8.8qリン酸−ナトリウム(2水塩) 4.4
ffリン酸二ナトリウム(12水塩)25.8ηC,ビ
オチン 0.25ny塩化ナトリ
ウム 8.8〜リン酸−ナトリウム(2
水り 4.4岬リン酸二ナトリウム(12水塩)
2&8+1Wd、ピオチy O
,125nf塩化ナトリウム 8.8〜
リン酸−ナトリウム(2水塩) 4.4111Pリン
酸二ナトリウム(12水塩)25.8ff以上、−dと
もに常法に従い、凍結乾燥し、各々バイアルに充填する
。それぞれ用時に、蒸留水にて溶解し1dとして使用す
る。Example 5゜1, Biotin standard a, Biotin 1.0ny Sodium chloride 8.8 Kirin Sodium (dihydrate) 4.411F Disodium phosphate (1decahydrate) 25.811fb, Biotin
0.5nt sodium chloride
8.8q Sodium phosphate (dihydrate) 4.4
ff Disodium phosphate (12 hydrate) 25.8ηC, biotin 0.25ny Sodium chloride 8.8 ~ Sodium phosphate (2
Water 4.4 Misaki Disodium Phosphate (Decahydrate)
2&8+1Wd, Piochi y O
, 125nf Sodium chloride 8.8~
Sodium phosphate (dihydrate) 4.4111P disodium phosphate (dodecahydrate) Both 25.8ff and -d are freeze-dried according to a conventional method and filled into vials. When each is used, it is dissolved in distilled water and used as 1d.
2、検体希釈液
塩化ナトリウム 438.3〜リン酸−
ナトリウム(2水塩) 218.4nwiリン醗
二ナトリウム(12水塩) 1290.6++v上記
組成金常法に従い凍結乾燥し、バイアルに充填する。用
時蒸留水にて溶解し、50wt1として使用する。2. Specimen dilution solution Sodium chloride 438.3~Phosphoric acid-
Sodium (dihydrate) 218.4 nwi Phosphorus disodium (12 hydrate) 1290.6++v Lyophilize according to the conventional method for the above composition and fill into vials. Before use, dissolve in distilled water and use as 50wt1.
3、オルトフェニレンジアミン
オルトフェニレンジアミン 150.Ovリン酸−
ナトリウム(2水壇) 68.4Wqリン酸二ナト
リウム(12水塩) 22.OWq上記組成を常法
に従い凍結乾燥し、バイアルに充填する。用時0. O
I V/v96過酸化水素水にて溶解し、5Qdとして
使用する。3. Orthophenylenediamine Orthophenylenediamine 150. Ov phosphoric acid-
Sodium (dihydrate) 68.4Wq Disodium phosphate (decahydrate) 22. OWqThe above composition is freeze-dried according to a conventional method and filled into vials. When used: 0. O
Dissolve in IV/v96 hydrogen peroxide solution and use as 5Qd.
4、アビジン・パーオキシダーゼ
アビジノ・パーオキシダーゼ 800.Ony塩化ナ
トリウム 87.6■リン酸−ナトリ
ウム(2水塩) 43.7qリン酸二ナトリウム(
12水[) 258.1ηBSA
40.0■上記組成を常法に
従い凍結乾燥し、バイアルに充填したもの、あるいは上
記組成をそのまま用時0.1 % Tween−20溶
液に溶解し、10Mとして使用する。4. Avidin peroxidase Avidino peroxidase 800. Ony sodium chloride 87.6■ Sodium phosphate (dihydrate) 43.7q Disodium phosphate (
12 Water [) 258.1ηBSA
40.0 ■ The above composition is lyophilized according to a conventional method and filled into a vial, or the above composition is dissolved in a 0.1% Tween-20 solution and used as 10M.
&固定化−ビオチン化ポリリジン
ビオチン化ポリリジン 1 d(実施例1
.1)で作製したもの)
塩化ナトリウム 87.6#9リン酸
−ナトリウム(2水塩) 4.11Fリン酸二ナ
トリウム(12水塩) 25.8F上記組成を常法
に従い凍結乾燥し、バイアルに充填し走もの、あるいは
上記組成をそのまま用時蒸留水に溶解して10mとし、
96穴U底プレートの各穴に100μI?:入れ、実施
例1. II)の方法によりビオチン化ポリリジンの固
定化全行ない作製する。& Immobilization - Biotinylated polylysine Biotinylated polylysine 1 d (Example 1
.. 1)) Sodium chloride 87.6 #9 Sodium phosphate (dihydrate) 4.11F Disodium phosphate (1decahydrate) 25.8F The above composition was freeze-dried according to a conventional method and placed in a vial. Fill it with a running material or dissolve the above composition as it is in distilled water at the time of use to make 10 m,
100 μI in each hole of a 96-well U-bottom plate? : Put, Example 1. All immobilization of biotinylated polylysine is prepared by the method II).
以上that's all
Claims (1)
および標識アビジンを加え、当該ビオチン化蛋白質に結
合した標識体活性を測定し、これを標準液のそれと比較
することを特徴とするビオチンの測定法。 2、標識アビジンおよび固定化−ビオチン化蛋白質を含
有するビオチン測定用試薬。[Claims] 1. Immobilization - Adding a biotin-containing test solution and labeled avidin to a biotinylated protein, measuring the activity of the labeled substance bound to the biotinylated protein, and comparing this with that of a standard solution. A biotin measurement method characterized by: 2. A reagent for measuring biotin containing labeled avidin and an immobilized biotinylated protein.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27252884A JPS61149863A (en) | 1984-12-24 | 1984-12-24 | Measuring method of biotin and reagent for measurement to be used therein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27252884A JPS61149863A (en) | 1984-12-24 | 1984-12-24 | Measuring method of biotin and reagent for measurement to be used therein |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS61149863A true JPS61149863A (en) | 1986-07-08 |
Family
ID=17515147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27252884A Pending JPS61149863A (en) | 1984-12-24 | 1984-12-24 | Measuring method of biotin and reagent for measurement to be used therein |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61149863A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2335490A (en) * | 1998-03-20 | 1999-09-22 | Ortho Clinical Diagnostics | Assay surface comprising a biotin complex |
US9903923B2 (en) | 2014-01-22 | 2018-02-27 | Bruker Biospin Ag | Shuttle for an NMR MAS rotor |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5830667A (en) * | 1981-08-05 | 1983-02-23 | エフ・ホフマン−ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト | Labeled immunologically active substance |
-
1984
- 1984-12-24 JP JP27252884A patent/JPS61149863A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5830667A (en) * | 1981-08-05 | 1983-02-23 | エフ・ホフマン−ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト | Labeled immunologically active substance |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2335490A (en) * | 1998-03-20 | 1999-09-22 | Ortho Clinical Diagnostics | Assay surface comprising a biotin complex |
GB2335490B (en) * | 1998-03-20 | 2003-05-14 | Ortho Clinical Diagnostics | An assay surface that permits an analyte releasiing step |
US9903923B2 (en) | 2014-01-22 | 2018-02-27 | Bruker Biospin Ag | Shuttle for an NMR MAS rotor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Obayashi et al. | Formation of crossline as a fluorescent advanced glycation end productin vitroandin vivo | |
Blair et al. | Osteoclastic bone resorption by a polarized vacuolar proton pump | |
Greenough et al. | Titration of Cholera Enterotoxin and in Isolated Fat Cells | |
Chen et al. | Selenium deficiency affects uterine smooth muscle contraction through regulation of the RhoA/ROCK signalling pathway in mice | |
US7723056B1 (en) | Particles | |
BRPI1009071B1 (en) | METHOD FOR DETECTING A WOUND INFECTION, WOUND DRESSING AND FLEXIBLE STEM WITH COTTON IN THE END | |
Gonthier et al. | Determination of pantothenic acid in foods: influence of the extraction method | |
FR2678387A1 (en) | METHOD FOR THE IMMUNO-ENZYMATIC ASSAY OF VITAMIN B12 AND PREPARATION OF A SAMPLE FOR THE ASSAY | |
Wacker et al. | Magnesium/calcium balances and steady states of biological systems | |
FR2508486A1 (en) | IMMUNO-ENZYMATIC DETERMINATION METHOD AND KIT FOR IMPLEMENTING IT | |
JPS61149863A (en) | Measuring method of biotin and reagent for measurement to be used therein | |
EP0193439A1 (en) | Reagent for the determination by haemagglutination of antibodies against bacterial toxins, method for its preparation and its use | |
US3990946A (en) | Substrate for the determination of desoxy-ribonuclease | |
Farrell Jr et al. | β-Lactoglobulin and α-lactalbumin as potential modulators of mammary cellular activity: A Ca2+-responsive model system using acid phosphoprotein phosphatases | |
AU764247B2 (en) | Diagnosis of sepsis using the LPS-binding moiety of alkaline phosphatase | |
PT97511B (en) | ENZYME PROCESS FOR THE DETERMINATION OF BETA-LACTAMO NUCLEUS ANTIBIOTICS | |
JPS6171359A (en) | Biotin measurement method and measurement reagent used for this method | |
Ryszka et al. | Influence of prolactin and calcium gluconate concentration on permeation and intestinal absorption of Ca (II) ions | |
Ruaux et al. | Detection and measurement of canine α-macroglobulins by enzyme immuno-assay | |
JPS62159048A (en) | Method for measuring bioactivity of protein s | |
US4615877A (en) | Method of determining the oxidizing activity of a biological liquid, and a corresponding reagent | |
JPH07110331A (en) | Human complement value measuring method and reagent component for measuring the value | |
Cole et al. | A Comparison of Na+ Activation of ATPase in the Red Cell, Renal Cortex, and Renal Medulla | |
Blakeborough et al. | The effect of diets adequate and deficient in calcium on blood pressures and the activities of intestinal and kidney plasma membrane enzymes in normotensive and spontaneously hypertensive rats | |
Sarsam | Investigations into the Proteolytic Susceptibility of Non-Enzymically Glycated Connective Tissue Components of Periodontal and Endodontic Importance |